PhaseBio Pharmaceuticals Inc: 15-12G filed Sep 30, 2024

Form type

15-12G

Filing date

Sep 30, 2024

Accession number

0001193125-24-229002

Filer

PhaseBio Pharmaceuticals Inc (CIK 1169245)